In The Press September 04, 2020

Standing Firm: Why Medtech Remains Robust During A Downturn (MedTech Innovation News)

At a time when the UK, and the global economy, is experiencing one of its deepest recessions on record, medtech , perhaps unsurprisingly, is one area that is robust for mergers and acquisitions. David Mardle, a partner in Goodwin’s Technology and Life Sciences practice, explains that the robustness may be because of the broad range of sectors that medtech covers, with more digital health offerings and technology that can be supported by video calling and other virtual operations boosting the market. Read the article in MedTech Innovation News here.